Your browser doesn't support javascript.
loading
Dual dopamine D2 receptor and beta2-adrenoceptor agonists for the treatment of chronic obstructive pulmonary disease: the pre-clinical rationale.
Dougall, I G; Young, A; Ince, F; Jackson, D M.
Affiliation
  • Dougall IG; Department of Discovery BioScience, AstraZeneca R&D Charnwood, Loughborough, Leicestershire, UK. Iain.Dougall@astrazeneca.com
Respir Med ; 97 Suppl A: S3-7, 2003 Jan.
Article in En | MEDLINE | ID: mdl-12564606
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thiazoles / Receptors, Dopamine D2 / Adrenergic beta-Agonists / Pulmonary Disease, Chronic Obstructive / Adrenergic beta-2 Receptor Agonists Limits: Animals / Humans Language: En Journal: Respir Med Year: 2003 Document type: Article Affiliation country: Reino Unido
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thiazoles / Receptors, Dopamine D2 / Adrenergic beta-Agonists / Pulmonary Disease, Chronic Obstructive / Adrenergic beta-2 Receptor Agonists Limits: Animals / Humans Language: En Journal: Respir Med Year: 2003 Document type: Article Affiliation country: Reino Unido